Lista de obras -

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

artículo científico publicado en 2013

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

Allelic modification of breast cancer risk in women with an NBN mutation

scientific article published on 13 August 2019

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

artículo científico publicado en 2016

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

artículo científico publicado en 2019

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population

artículo científico publicado en 2018

CHEK2 mutations and the risk of papillary thyroid cancer.

artículo científico publicado en 2015

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

artículo científico publicado en 2015

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2016

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

artículo científico publicado en 2016

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations

artículo científico publicado en 2014

Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland

artículo científico publicado en 2022

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide association study of prostate cancer-specific survival

artículo científico publicado en 2015

Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2015

HOXB13 mutations and prostate cancer in Poland.

artículo científico publicado en 2012

Inherited NBN Mutations and Prostate Cancer Risk and Survival

scientific article published on 13 December 2018

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

artículo científico publicado en 2019

Inherited variants in XRCC2 and the risk of breast cancer

scientific article published on 28 August 2019

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

artículo científico publicado en 2015

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

artículo científico publicado en 2020

NBS1 Mutation and prognosis of prostate cancer

PALB2 mutations and prostate cancer risk and survival

artículo científico publicado en 2021

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Prediction of individual genetic risk to prostate cancer using a polygenic score

artículo científico publicado en 2015

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland

artículo científico publicado en 2020

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population

artículo científico publicado en 2020

Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study

artículo científico publicado en 2014

Prostate cancer screening based on genotyping for high risk founder alleles

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

artículo científico publicado en 2021

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population

artículo científico publicado en 2017

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

artículo científico publicado en 2013

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

artículo científico publicado en 2012

The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome

artículo científico publicado en 2016

The effect of sample size on polygenic hazard models for prostate cancer

artículo científico publicado en 2020

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

artículo científico publicado en 2013

The spectrum of mutations predisposing to familial breast cancer in Poland

scientific article published on 26 June 2019

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

artículo científico publicado en 2015

Lista de obras de

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Allelic modification of breast cancer risk in women with an NBN mutation

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

BARD1 is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation

BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population

CHEK2 mutations and the risk of papillary thyroid cancer.

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations

Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

Genome-wide association study of prostate cancer-specific survival

Germline RECQL mutations are associated with breast cancer susceptibility

HOXB13 mutations and prostate cancer in Poland.

Inherited NBN Mutations and Prostate Cancer Risk and Survival

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer

Inherited variants in XRCC2 and the risk of breast cancer

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland

NBS1 Mutation and prognosis of prostate cancer

PALB2 mutations and prostate cancer risk and survival

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

Prediction of individual genetic risk to prostate cancer using a polygenic score

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland

Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population

Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based study

Prostate cancer screening based on genotyping for high risk founder alleles

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome

The effect of sample size on polygenic hazard models for prostate cancer

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

The spectrum of mutations predisposing to familial breast cancer in Poland

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men